Efficacy and safety of nisoldipine coat core in the management of angina pectoris, systemic hypertension, and ischemic ventricular dysfunction
- 27 April 1995
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 75 (13) , E46-E53
- https://doi.org/10.1016/s0002-9149(99)80448-2
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- A proischaemic action of nisoldipine: relationship to a decrease in perfusion pressure and comparison to dipyridamoleCardiovascular Research, 1993
- Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris.Circulation, 1991
- Calcium channel blockers in chronic heart failure. The risks of "physiologically rational" therapy.Circulation, 1990
- A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure.Circulation, 1990
- Preservation of left ventricular performance with reduced ischemic dysfunction by intravenous nisoldipineThe American Journal of Cardiology, 1990
- NisoldipineDrugs, 1988
- The Effect of Diltiazem on Mortality and Reinfarction after Myocardial InfarctionNew England Journal of Medicine, 1988
- Effect of the second-generation calcium channel blocker nisoldipine on left ventricular contractility in cardiac failureAmerican Heart Journal, 1988
- Cardiac versus vascular effects of a new dihydropyridine derivative, CV-4093. In vitro comparison with other calcium antagonistsEuropean Journal of Pharmacology, 1988
- Chronic renal and neurohumoral effects of the calcium entry blocker nisoldipine in patients with congestive heart failureJournal of the American College of Cardiology, 1987